Penta-valent-vaccine is a combination vaccine administered in a 3-dose schedule, offers protection against diphtheria, tetanus, pertussis (DPT), hepatitis B, and Haemophilus influenza type B (Hib). The vaccine is widely recommended by WHO and GAVI as a substitute for prevailing vaccination practices against the above mentioned diseases and viruses. The vaccine has met with both positive and negative responses, which leads to uncertainties about the vaccine's safety. The pros and cons of the vaccine are to be evaluated carefully before the same is added to routine immunization schedule.
CITATION STYLE
Sreedhar, S., Antony, A., & Poulose, N. (2014). Study on the effectiveness and impact of pentavalent vaccination program in India and other south Asian countries. Human Vaccines and Immunotherapeutics, 10(7), 2062–2065. https://doi.org/10.4161/hv.28785
Mendeley helps you to discover research relevant for your work.